Search

everythinglearnresearchcommunity

for

Search:↓

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

A new model helps predict treatment success in girls with early puberty.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Deslorelin can help control reproduction and improve hair growth in German Spitz dogs.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

PCOS treatment focuses on inducing ovulation, reducing androgens, and managing long-term health risks with medications and lifestyle changes.